/주식/OCUL
OCUL

OCUL

USD

Ocular Therapeutix Inc. Common Stock

$10.900-0.300 (-2.679%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$11.200

고가

$11.355

저가

$10.400

거래량

1.84M

기업 기본 정보

시가총액

2.3B

산업

생명공학

국가

United States

거래 통계

평균 거래량

2.72M

거래소

NGM

통화

USD

52주 범위

저가 $5.785현재가 $10.900고가 $13.85

관련 뉴스

GlobeNewswire

Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights

Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability Announced today that SOL-R achieved target

더 보기
Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights
Analyst Upgrades

TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20

TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix with a Buy and raises the price target from $14 to $20.

더 보기
TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20
GlobeNewswire

Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025

BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans

더 보기
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025